↓ Skip to main content

The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders

Overview of attention for article published in Translational Neurodegeneration, July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
1 news outlet
twitter
2 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders
Published in
Translational Neurodegeneration, July 2022
DOI 10.1186/s40035-022-00308-y
Pubmed ID
Authors

Margrethe A. Olesen, Francisca Villavicencio-Tejo, Rodrigo A. Quintanilla

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 11%
Student > Master 6 11%
Researcher 4 7%
Student > Bachelor 2 4%
Student > Postgraduate 2 4%
Other 7 13%
Unknown 29 52%
Readers by discipline Count As %
Neuroscience 6 11%
Biochemistry, Genetics and Molecular Biology 6 11%
Agricultural and Biological Sciences 2 4%
Medicine and Dentistry 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Other 5 9%
Unknown 34 61%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2022.
All research outputs
#3,346,176
of 25,392,582 outputs
Outputs from Translational Neurodegeneration
#157
of 385 outputs
Outputs of similar age
#70,800
of 438,841 outputs
Outputs of similar age from Translational Neurodegeneration
#5
of 9 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 385 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.7. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,841 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.